This collaboration will leverage Kenox Pharmaceuticals' extensive expertise in nasal and inhaled pharmaceutical ... novel therapies designed to enhance mucosal immunity in individuals with ...

PRINCETON, N.J., March 10, 2025 /PRNewswire/ -- Kenox Pharmaceuticals Inc. and Lactiga US, Inc. are pleased to announce a strategic collaboration to advance the development of novel, groundbreaking, ...

As cold and flu season continues to surge, a popular nasal spray used to relieve symptoms of nasal congestion, sinusitis, and allergies has been recalled in a recent FDA announcement. The recall ...

Mucosal atomization devices are increasingly used in the management of chronic conditions such as allergic rhinitis, asthma, migraine, and chronic pain. They provide targeted drug delivery to the ...

Nasal anti-CD3 monoclonal antibody ameliorates traumatic brain injury, enhances microglial phagocytosis and reduces neuroinflammation via IL-10-dependent Treg–microglia crosstalk. Nature ...

A nasal cleansing wash sold nationwide is being recalled because the product may be contaminated with bacteria, according to a notice posted this week by the U.S. Food and Drug Administration.

particularly for individuals with compromised nasal mucosa. S. aureus contamination can lead to blood infections and potentially severe secondary infections, including endocarditis, bone and joint ...